Logicbio Therapeutics Inc (LOGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOGC | BMY | AMGN | GILD | VRTX |
| Company | Logicbio Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.06 | 47.93 | 265.64 | 67.01 | 394.19 |
| High | 2.07 | 47.93 | 265.64 | 67.02 | 394.61 |
| Low | 2.06 | 47.68 | 264.41 | 66.75 | 393.44 |
| Last | 2.07 | 47.82 | 264.02 | 66.40 | 392.70 |
| Change | +0.01 | -0.02 | -0.05 | -0.53 | -0.40 |
| % Change | +0.49% | -0.04% | -0.02% | -0.79% | -0.10% |
| Volume | 153,000 | 267,903 | 40,832 | 160,439 | 3,935 |
| 20-Day Average Volume | 260,175 | 10,887,075 | 2,099,807 | 5,900,822 | 862,227 |
| Previous Close | 2.06 | 47.84 | 264.07 | 66.93 | 393.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.06 | 50.96 | 273.10 | 70.25 | 406.60 |
| 20-Day Raw Stochastic | 100.00% | 1.89% | 8.04% | 1.73% | 5.87% |
| 20-Day Relative Strength | 85.25% | 34.55% | 39.31% | 29.57% | 37.19% |
| Weighted Alpha | -67.30 | -31.14 | +5.73 | -24.13 | +15.73 |
| Today's Opinion | 100% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 96% Buy | 56% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 80% Buy | 24% Sell | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 11/08/22 | -2.67% since 04/11/24 | -1.70% since 04/11/24 | -2.58% since 04/11/24 | -1.62% since 04/11/24 |
| Low | 2.06 on 11/15/22 | 47.68 on 04/18/24 | 263.39 on 04/17/24 | 66.75 on 04/18/24 | 392.03 on 04/17/24 |
| High | 2.07 on 11/15/22 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.98% since 10/14/22 | -7.33% since 03/18/24 | -2.03% since 03/18/24 | -8.71% since 03/18/24 | -4.28% since 03/18/24 |
| Low | 2.03 on 10/17/22 | 47.68 on 04/18/24 | 263.39 on 04/17/24 | 66.75 on 04/18/24 | 392.03 on 04/17/24 |
| High | 2.07 on 11/15/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +301.94% since 08/15/22 | -4.55% since 01/18/24 | -12.83% since 01/18/24 | -22.59% since 01/18/24 | -9.06% since 01/18/24 |
| Low | 0.26 on 09/28/22 | 47.58 on 02/06/24 | 263.39 on 04/17/24 | 66.75 on 04/18/24 | 392.03 on 04/17/24 |
| High | 2.07 on 11/15/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +381.40% since 05/13/22 | -15.90% since 10/18/23 | -6.41% since 10/18/23 | -16.05% since 10/18/23 | +7.13% since 10/18/23 |
| Low | 0.26 on 09/28/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 66.75 on 04/18/24 | 341.90 on 11/16/23 |
| High | 2.07 on 11/15/22 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 68,233 | 96,960,152 | 141,520,144 | 83,333,008 | 101,600,240 |
| Shares Outstanding, K | 32,963 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 5,410,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -40,030,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,200,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,040,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 4.61 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/14/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/21/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 29.33 |